Infanrix hexa, Powder and suspension for suspension for injection

Company: GlaxoSmithKline (Ireland) Ltd
Active Ingredient: Diphtheria (D), Tetanus (T), Pertussis (acellular, component) (Pa), Hepatitis B (rDNA) (HBV), Poliomyelitis (inactivated) (IPV) and Haemophilus Type B (Hib) Conjugate Vaccine (adsorbed).
Strength: Diphtheria (D), Tetanus (T), Pertussis (acellular, component) (Pa), Hepatitis B (rDNA) (HBV), Poliomyelitis (inactivated) (IPV) and Haemophilus Type B (Hib) Conjugate Vaccine (adsorbed).: 5 ml
Dosage Form: Suspension for injection
Legal Category: A - prescription, may not be renewed
Last Updated: 25/09/2026

Direct Healthcare Professional Communications

Infanrix Hexa - DHPC

Direct Healthcare Professional Communication (DHPC)

PDF303.08 KB

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland, D24 Dublin